 | |||||
| today deals | |||||
| NEWS | |||||
| Pepper Bio spices up pipeline with $135M deal for G1 Therapeutics' CDK4/6 inhibitor Preclinical testing backed up the hypothesis that lerociclib could work on this type of cancer, leading Pepper to seal today's deal ahead of entering ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment